Hospital Nacional Cayetano Heredia; Ocología; Servicio de Hematología Oncología Médica
Lima 15102
0 studies enrolling now · 1 studies all time
What they study most
Breast Cancer
Studies at this site
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
— Completed